Mahendra Shah

Dr. Shah has served as a Non-Executive Director on the board of directors since July 2016.

Dr. Shah, the Senior Fellow of Vivo Capital, was formerly a Managing Partner at the healthcare investment firm. Dr. Shah is also the founder and Executive Chair of Semnur Pharmaceuticals (acquired by Scilex Pharmaceuticals), a specialty pharmaceutical company. Dr. Shah previously served as a board member of Soleno Therapeutics, Crinetics Pharmaceuticals, Aadi Bioscience, and Homology Medicines. He currently serves as a member of the board of directors of several private companies in the biopharmaceutical and biotechnology industries. Dr. Shah received his Ph.D. in industrial pharmacy from St John’s University and a Master’s Degree in Pharmacy from LM College of Pharmacy in Gujarat, India.